Effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise

F. C. Blumberg, G. A. J. Riegger, M. Pfeifer (Regensburg, Germany)

Source: Annual Congress 2001 - Pulmonary hypertension: effect of iloprost
Session: Pulmonary hypertension: effect of iloprost
Session type: Oral Presentation
Number: 2165
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. C. Blumberg, G. A. J. Riegger, M. Pfeifer (Regensburg, Germany). Effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise. Eur Respir J 2001; 16: Suppl. 31, 2165

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of nebulised iloprost on pulmonary function and oxygenation in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002

Inhaled iloprost improves hemodynamics at exercise in primary and secondary precapillary pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002

Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 17: 1334-1335
Year: 2001


Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 18: 247
Year: 2001


Inhalation of a prostacyclin analog (iloprost) does not improve exercise capacity in COPD with disproportional pulmonary hypertension
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002

Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 17: 8-13
Year: 2001



Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol
Source: Eur Respir J 2001; 18: Suppl. 33, 323s
Year: 2001

Inhaled iloprost reverses chronic experimental pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 353s
Year: 2005

Effects of inhaled Iloprost on hemodynamics in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 27s
Year: 2002

Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 339-343
Year: 2002



Influence of inhaled iloprost on transpulmonary gradient of big-endothelin in patients with pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002

Long-term treatment with oral sildenafil in addition to chronic prostacyclin therapy improves pulmonary hemodynamics and six minute walking test in patients with pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002

Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension
Source: Eur Respir J 2001; 17: 14-19
Year: 2001



Experience with inhaled iloprost in paediatric pulmonary arterial hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011


Effects of inhaled salbutamol in primary pulmonary hypertension
Source: Eur Respir J 2002; 20: 524-528
Year: 2002



Effects of sildenafil on secondary pulmonary hypertension in highlanders with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007

Inhaled iloprost plus oral sildenafil in patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001

Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017


Acute response of iloprost inhalation using the Breelib nebulizer in pulmonary arterial hypertension: the Breelib acute study
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018